Work is performed in the subgroup PRELIM in Translational Molecular Imaging of Cancer(Prof. McCormack) and in the Signalling targeted therapy group(Prof. Gjertsen)
Affiliated with CCBIO
- 2019. A kinase inhibitor with anti-Pim kinase activity is a potent and selective cytotoxic agent toward acute myeloid leukemia. Molecular Cancer Therapeutics. 18: 567-578. doi: 10.1158/1535-7163.MCT-17-1234
- 2016. The past, present and future subclassification of patients with acute Myeloid Leukemia. Current Pharmaceutical Biotechnology. 17: 6-19. doi: 10.2174/1389201016666150907113653
- B.Sc in Biology at the University of Bergen (2013)
- M.Sc in Biomedicine - Medical cell Biology at the University of Bergen (2015) with the thesis "Exploring the anti-leukaemic effect of the small-molecule dynamin GTPase inhibitor; Dynasore, in Acute Myeloid Leukaemia."